Ameriprise Financial Inc Bio Techne Corp Transaction History

Ameriprise Financial Inc

$358 Billion
Q1 2024

A detailed history of Ameriprise Financial Inc transactions in Bio Techne Corp stock. As of the latest transaction made, Ameriprise Financial Inc holds 3,281,069 shares of TECH stock, worth $253 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

3,281,069

Previous 2,021,718 62.29%

Holding current value

$253 Million

Previous $156 Million 48.05%

% of portfolio

0.06%

Previous 0.05%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$65.98 - $77.09 $83.1 Million - $97.1 Million	1,259,351 Added 62.29%	3,281,069 $231 Million
Q4 2023 Feb 14, 2024	SELL	$52.83 - $78.22 $7.3 Million - $10.8 Million	-138,237 Reduced 6.4%	2,021,718 $156 Million
Q3 2023 Nov 14, 2023	SELL	$67.52 - $89.42 $68.5 Million - $90.8 Million	-1,015,071 Reduced 31.97%	2,159,955 $147 Million
Q2 2023 Aug 14, 2023	BUY	$73.76 - $85.98 $9.74 Million - $11.3 Million	132,006 Added 4.34%	3,175,026 $259 Million
Q1 2023 May 15, 2023	BUY	$71.62 - $86.62 $40.6 Million - $49.1 Million	566,681 Added 22.88%	3,043,020 $226 Million

Q4 2022 Feb 14, 2023	BUY	$80.67 - $352.29 $150 Million - $655 Million	1,857,914 Added 300.43%	2,476,339 $205 Million
Q3 2022 Nov 14, 2022	SELL	$282.54 - $391.85 $700,416 - $971,396	-2,479 Reduced 0.4%	618,425 $176 Million
Q2 2022 Aug 15, 2022	SELL	$322.67 - $449.65 $1.71 Million - $2.38 Million	-5,302 Reduced 0.85%	620,904 $215 Million
Q1 2022 May 16, 2022	BUY	$353.85 - $487.79 $39 Million - $53.7 Million	110,149 Added 21.34%	626,206 $271 Million
Q4 2021 Feb 14, 2022	BUY	$456.15 - $525.06 $14.2 Million - $16.3 Million	31,132 Added 6.42%	516,057 $267 Million
Q3 2021 Nov 15, 2021	SELL	$444.87 - $538.88 $81 Million - $98.1 Million	-182,029 Reduced 27.29%	484,925 $235 Million
Q2 2021 Aug 16, 2021	BUY	$387.35 - $450.26 $12.9 Million - $15 Million	33,291 Added 5.25%	666,954 $300 Million
Q1 2021 May 17, 2021	SELL	$314.62 - $411.0 $22.8 Million - $29.8 Million	-72,481 Reduced 10.26%	633,663 $242 Million
Q4 2020 Feb 12, 2021	BUY	$246.9 - $321.87 $5.52 Million - $7.2 Million	22,372 Added 3.27%	706,144 $224 Million
Q3 2020 Nov 16, 2020	SELL	$232.22 - $282.96 $7.61 Million - $9.28 Million	-32,781 Reduced 4.57%	683,772 $169 Million
Q2 2020 Aug 14, 2020	BUY	$185.43 - $279.56 $11.7 Million - $17.6 Million	62,839 Added 9.61%	716,553 $189 Million
Q1 2020 May 15, 2020	SELL	$161.17 - $221.51 $11 Million - $15.1 Million	-68,170 Reduced 9.44%	653,714 $124 Million
Q4 2019 Feb 14, 2020	BUY	$189.68 - $222.09 $1.68 Million - $1.97 Million	8,848 Added 1.24%	721,884 $158 Million
Q3 2019 Nov 14, 2019	BUY	$183.56 - $216.72 $22.6 Million - $26.6 Million	122,928 Added 20.83%	713,036 $140 Million
Q2 2019 Aug 14, 2019	BUY	$188.72 - $215.43 $6.73 Million - $7.69 Million	35,679 Added 6.44%	590,108 $123 Million
Q1 2019 May 15, 2019	BUY	$136.09 - $200.44 $9.04 Million - $13.3 Million	66,453 Added 13.62%	554,429 $110 Million
Q4 2018 Feb 14, 2019	SELL	$132.75 - $203.8 $21.6 Million - $33.2 Million	-162,773 Reduced 25.01%	487,976 $70.6 Million
Q3 2018 Nov 14, 2018	SELL	$147.44 - $204.11 $10.8 Million - $15 Million	-73,326 Reduced 10.13%	650,749 $133 Million
Q2 2018 Aug 14, 2018	BUY	$144.9 - $165.58 $38.8 Million - $44.4 Million	267,964 Added 58.75%	724,075 $107 Million
Q1 2018 May 15, 2018	BUY	$131.46 - $151.04 $23 Million - $26.5 Million	175,331 Added 62.44%	456,111 $68.9 Million
Q4 2017 Feb 12, 2018	BUY	$121.17 - $134.75 $9.61 Million - $10.7 Million	79,294 Added 39.35%	280,780 $36.4 Million
Q3 2017 Nov 07, 2017	BUY	$113.59 - $123.78 $22.9 Million - $24.9 Million	201,486	201,486 $24.4 Million

Others Institutions Holding TECH

# of Institutions

581

Shares Held

154M

Call Options Held

180K

Put Options Held

189K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $3.03B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Bio Techne Corp Transaction History